Pre-Election Special SALE: 60% Off VIP Membership
BREAKING: Supreme Court Rules on Whether Virginia Can Remove Non-Citizens From Voter Rolls
Tim Walz's Gaming Session With Ocasio-Cortez Was a Trainwreck
Oregon Predicates Request to Judge on Self-Delusion
GDP Report Shows Economy 'Weaker Than Expected'
How Trump Plans to Help Compensate Victims of 'Migrant Crime'
NRCC Blasts the Left's Voter Suppression Efforts in Battleground Districts
Watch Trump's Reaction to Finding Out Biden Called His Supporters 'Garbage'
Scott Jennings Calls Out CNN Host, Panelists Trying to Desperately Explain Away Biden's...
There Was a Vile, Violent Attack in Chicago, and the Media's Been Silent....
One Red State Just Acquired a Massive Amount of Land to Secure Its...
Poll Out of Texas Shows That Harris Rally Sure Didn't Work for Colin...
This Hollywood Actor Is Persuading Christian Men to Vote for Kamala Harris
Is the Trump Campaign Over-Confident?
Is This Really How the Kamala HQ Is Going to Respond to Biden’s...
OPINION

Innovation vs. Intervention in Health Care

The opinions expressed by columnists are their own and do not necessarily represent the views of Townhall.com.
Advertisement
Advertisement
Advertisement
Editor's Note: Steve Chapman is off. The following column is by Veronique de Rugy.

How can we produce better health for more people at a lower cost, year after year? By lifting all the rules and barriers that prevent health care innovators from bringing new lifesaving products to consumers and force doctors to beg bureaucrats and insurance administrators for permission to save lives.

Advertisement

For years, free market types focused most of their attention on how to provide better health insurance coverage than their liberal counterparts. But is this the right approach? Health care coverage is different from health care. Though introducing more consumer choices and competition among health care suppliers certainly affects health care prices, nothing would have as radical an impact on prices and quality in the health care industry as revolutionary innovation -- which we've seen in other fields, e.g., information technology.

For that, we must first free the health care supply from the many constraints imposed by federal and state governments and the special interests they serve.

At the federal level, that means, among other things, radically reforming the Food and Drug Administration. The FDA is the perfect example of an agency that works by the "precautionary principle" norm. In the name of protecting people from everything at any cost -- even against their will, if need be -- it imposes an incredible regulatory burden on health care innovators, which then translates into higher costs and fewer new products available to consumers.

In some cases, the FDA's intervention in the health care market slows down access to certain drugs, or it makes some drugs and technologies unaffordable to low-income individuals. In other cases, it actually drives innovators out of the market. In extreme cases, it kills people who could have been saved if they had had access to a drug or a technology.

Advertisement

As laudable as the efforts by Congress to reform the FDA have been, they haven't worked. One reason is the tendency of the agency to be captured by special interest groups. For instance, large, established pharmaceutical companies might complain about the cost of new regulations, but they are well aware that their competitors will bear these same burdens. Smaller upstarts, however, are thwarted by the heavy cost of regulation before they even get a chance to enter the market.

So what can be done? Some argue that the only way to productively reform the FDA would be to allow for a private alternative. In The Wall Street Journal last year, neurosurgeon-scientist and entrepreneur Kevin Tracey described such an alternative. He wrote: "Institutional review boards and human-subject research protocols provide extremely high levels of protection overseeing clinical trials in the U.S. and Europe. These bodies have weeded out the charlatans in the industry, and the ultimate determinant of success will be patient satisfaction."

Others suggest getting rid of federal and state regulations that prevent people from having access to more and better information about drugs, medical devices and procedures; forbid them to try new, unapproved drugs when they or their loved ones are terminally ill; and preclude doctors from offering new treatments to their patients. As my colleague Adam Thierer at the Mercatus Center told me, "we should focus on ensuring patients a 'right to know' and 'right to try,' and doctors should have a 'right to heal.' It's time to put patients first and trust them."

Advertisement

Indeed, people often are better-suited to know what is best for them than bureaucrats in Washington. Moreover, these reforms would be important first steps to allow tech innovators to work their magic in health care. This would result in spectacular reductions of health care costs -- making the need for health insurance much less important than it is now.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos